FIELD: medicine.
SUBSTANCE: separation of the mononuclear leukocyte cell suspension from patient's blood is performed by density fractionation. The cell suspension is used immediately after centrifugation of 4 mL blood. The suspension is washed out and diluted by 3.0 mL isotonic sodium chloride. The suspension is instilled 6-8 times daily with 3-4 days break, the course consists of 2-3 procedures.
EFFECT: method increases efficiency of treatment by reduction of treatment time.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING DEEP STROMAL KERATITES | 2010 |
|
RU2440801C1 |
METHOD OF SURGICAL TREATMENT OF ENDOTHELIAL-EPITHELIAL DYSTROPHY OF CORNEA | 2017 |
|
RU2674237C1 |
METHOD OF TREATING ENDOTHELIAL EPITHELIAL CORNEAL DYSTROPHY | 2015 |
|
RU2601317C1 |
METHOD FOR MODELING PROLIFERATIVE VITREORETINOPATHY | 2000 |
|
RU2182369C2 |
METHOD FOR SURGICAL TREATMENT OF KERATECTASIA OF VARIOUS ORIGINS | 2022 |
|
RU2780273C1 |
METHOD OF TREATING POSTERIOR UVEITIS | 2013 |
|
RU2546956C2 |
METHOD OF TREATING AGE-RELATED WET MACULAR DEGENERATION | 2013 |
|
RU2541834C1 |
METHOD FOR THROMBOSIS TREATMENT IN CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2007 |
|
RU2337656C1 |
MEDICATION, METHOD OF OBTAINING MEDICATION, AND METHOD OF TREATMENT FOR CORNEA EDEMA AND OTHER EARLY BULLOUS KERATOPATHY MANIFESTATIONS | 2008 |
|
RU2357743C1 |
METHOD FOR CULTURING BLOOD MONONUCLEAR CELLS IN VITRO | 2002 |
|
RU2221039C1 |
Authors
Dates
2008-05-20—Published
2006-11-21—Filed